Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Post by wildbird1on Apr 14, 2019 9:55am
240 Views
Post# 29624368

'' Notes''

'' Notes''Notes from the ''Earnings Transcript''.

Proven...
GEN Said ''Scientific groups have looked at the paper, the report that we have got back is that our science is definitively proven, it is not promised. And I am going to come back to that, it is proven, it's not promised. Remember that the competitors in our space are still working on this science, we are not, ours work. ''

Well in excess of 1%...
GEN Said '' Catastrophic claims, its generally a small percentage of claims that drive the majority of the costs in these multibillion-dollar self funded fund. If you offer them a 1% saving, you generally get their attention, in our case we offer them saving well in excess of that 1%.''

Better than $30 million...
GEN Said '' If you shoot for $30 million in revenue, you've got a chance of making $30 million in revenue. If you shoot for $2 billion in revenue, you may not make $2 billion in revenue, but you're absolutely certainly going to do a lot better than $30 million in revenue.''

The SP...
In between news releases (good or bad) the SP always fluctuate, some speculators will take advantage of this situation to scare you out of your shares, it's OK, it's part of the game of investing in a small cap. Just make sure you come back in before Big News start to come out.

With the new team(GEN+ Lifex) I wouldn't take the chance of being without my GEN shares. If you take the time to read the '' Earnings Transcript'' you will realise that a big deal could come out any time now.

Control your destiny or somebody else will(like a speculator).
Jack Welch.


Bullboard Posts